User:Mr. Ibrahem/Lusutrombopag

Lusutrombopag, sold under the brand name Mulpleta among others, is a medication used to treat low platelets due to chronic liver disease. It is used before surgery. It is taken by mouth.

Common side effects include headache. Other side effects may include nausea, portal vein thrombosis, and rash. It is a thrombopoietin receptor agonist which increases platelet numbers.

Lusutrombopag was approved in the United States in 2018 and Europe in 2019. In the United Kingdom a course of treatment costs the NHS about £800. In the United States this amount costs about 8,900 USD.